Veru to present at the h.c. wainwright 25th annual global investment conference on september 11th, 2023

Miami, aug. 30, 2023 (globe newswire) -- veru inc. (nasdaq: veru), a late clinical stage biopharmaceutical company focused on developing novel medicines for metastatic breast cancer and for viral induced acute respiratory distress syndrome (ards), today announced that mitchell steiner, m.d., chairman, president and chief executive officer of veru, will present at the h.c. wainwright 25th annual global investment conference to be held at the lotte new york palace hotel in new york city on monday, september 11th, 2023 at 9:00 a.m. et.
VERU Ratings Summary
VERU Quant Ranking